Affiliation:
1. Receptor Technologies Inc., 276 East Allen, Winooski, Vermont 05404
Abstract
Using mammalian cells transiently transfected with receptors, we have developed an assay [Receptor Selection and Amplification Technology (R-SAT); patents pending] that links ligand-dependent cellular transformation to induction of 8-galactosidase in a 96-well plate format. Using these procedures, we have performed high throughput functional assays of receptors that mediate signal transduction by a diversity of mechanisms. Examples include the prostanoid, muscarinic, and neurokinin receptor subtypes that signal via the G-proteins Gq and Gi, the JAK/STAT-linked GM-CSF receptor, the tyrosine kinase neurotrophin receptors, and the classical oncogenes v-ras and p53. The assays have been formatted such that many receptors can be assayed simultaneously (>10 receptors per well) and precise discrimination of ligand efficacy can be obtained (e.g., full and partial agonists, negative and neutral antagonists).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献